Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort

In asymptomatic, middle-aged U.S. adults, LiverMultiScan PDFF estimated NAFLD prevalence at 38% and biopsy-confirmed NASH prevalence was 14%. NASH associated with race, obesity, and diabetes. These findings underscore LiverMultiScan’s suitability for scalable population assessment to identify at-risk individuals and enrich NASH cohorts.